Final hours! Save up to 55% OFF InvestingProCLAIM SALE

6 biggest insider trades: Asana CEO to buy 30 million shares | Pro Recap

Published 12/03/2023, 16:12
© Reuters.
KDP
-
IXIC
-
TTI
-
OPK
-
ASAN
-
SOFI
-
FIGS
-

By Davit Kirakosyan

Investing.com -- Here are the 6 biggest insider trades from the past week you may have missed on InvestingPro. Start your free 7-day trial to get this news first.

Asana CEO plans to buy 30 million shares

Asana (NYSE:ASAN) shares jumped more than 18% on Thursday after its Q4 beat and the CEO announced he plans to buy more shares of the company.

CEO Dustin Moskovitz, who purchased 19M shares of Asana stock in September 2022, announced an additional 30M share trading agreement, further demonstrating his faith in the company and removing any doubt surrounding Asana's liquidity.

SoFi Technologies CEO buys $1M shares

SoFi Technologies (NASDAQ:SOFI) CEO, Anthony Noto, bought 180,000 shares, or nearly $1M worth, at approximately $5.53. The purchase brought his stake to 5,984,110 shares.

However, shares plunged more than 8% on Friday, likely related to contagion issues related to SVB, with the volume being heavier than normal.

Keurig Dr Pepper CFO buys $1.7M shares

Keurig Dr Pepper (NASDAQ:KDP) CFO, Sudhanshu Shekhar Priyadarshi, bought 50,000 shares, or around $1.7M worth, at $34.3-$34.47.

At the end of February, Priyadarshi bought a separate 20,000 shares worth $711,800.

The company will report its Q1/23 earnings on April 27.

3 more insider buys

  • Figs (NYSE:FIGS) CEO, Catherine Eva Spear, bought 790,000 shares, or nearly $5M worth, at $6.0616-$6.3159.

Shares fell nearly 12% this week.

  • Tetra Technologies (NYSE:TTI) saw several insider buys this week, including from the CEO and CFO.

CEO Brady Murphy, bought 30,000 shares, or around $100,000 worth, at $3.41. CFO Elijio Serrano, bought 30,000 shares, or around $100,000 worth, at $3.45.

SVP - Supply Chain & Chemicals, Timothy Moeller, bought 7,250 shares, or around $25,000 worth, at $3.44. EVP Matthew Sanderson, bought 7,500 shares, or around $25,000 worth, at $3.40.

Shares closed around 10% lower this week.

  • Opko Health (NASDAQ:OPK) CEO/Chairman, Phillip Frost, bought 1M shares, or around $1.17M worth, at $1.12-$1.29.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.